SBH
UTMD icon

Segall Bryant & Hamill’s Utah Medical Products UTMD Stock Holding History

Segall Bryant & Hamill’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Buy
21,547
+10,065
+88% +$634K 0.02% 467
2025
Q4 		$643K Sell
11,482
-53
-0.5% -$3.07K 0.01% 537
2025
Q3 		$726K Buy
+11,535
New +$682K 0.01% 522

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Segall Bryant & Hamill's UTMD Position: Q1 2026 in Review

Segall Bryant & Hamill increased its Utah Medical Products (UTMD) stake by 88% in Q1 2026, buying an estimated $634K and bringing the position to 21,547 shares worth $1.34M. The position accounts for 0.02% of the portfolio, ranked #467.

Segall Bryant & Hamill first reported a position in UTMD in Q3 2025 and has held it in 3 quarters since. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Segall Bryant & Hamill held 21,547 shares of Utah Medical Products worth $1.34M as of Q1 2026.
  • Segall Bryant & Hamill bought 10,065 Utah Medical Products shares in Q1 2026, an estimated $634K.
  • Utah Medical Products made up 0.02% of Segall Bryant & Hamill's portfolio in Q1 2026, its #467 holding.
  • Segall Bryant & Hamill first reported a position in Utah Medical Products in Q3 2025 and has held it in 3 quarters since.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.